147 related articles for article (PubMed ID: 12771296)
1. Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients.
Fukagawa M; Kitaoka M; Tominaga Y; Akizawa T; Kakuta T; Onoda N; Koiwa F; Yumita S; Kurokawa K;
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii31-3. PubMed ID: 12771296
[TBL] [Abstract][Full Text] [Related]
2. [PEIT is the part of strategy for severe hyperparathyroidism in patients requiring hemodialysis].
Uemura K; Kakuta T
Clin Calcium; 2004 Sep; 14(9):88-92. PubMed ID: 15577118
[TBL] [Abstract][Full Text] [Related]
3. Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography.
Tanaka R; Kakuta T; Fujisaki T; Tanaka S; Sakai H; Kurokawa K; Saito A
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii58-61. PubMed ID: 12771303
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention.
Goto S; Komaba H; Fukagawa M
NDT Plus; 2008 Aug; 1(Suppl 3):iii2-iii8. PubMed ID: 25983967
[TBL] [Abstract][Full Text] [Related]
5. Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients.
Yamamoto H; Katoh N; Takeyama H; Ikeda M; Yokoyama K; Shigematsu T; Kawaguchi Y; Hosoya T
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii50-2. PubMed ID: 12771301
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients.
Kakuta T; Fukagawa M; Fujisaki T; Hida M; Suzuki H; Sakai H; Kurokawa K; Saito A
Am J Kidney Dis; 1999 Jun; 33(6):1091-9. PubMed ID: 10352197
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Nephron Clin Pract; 2006; 102(1):c1-7. PubMed ID: 16166800
[TBL] [Abstract][Full Text] [Related]
8. Changes in interventional treatment--from the viewpoint of percutaneous ethanol injection therapy.
Kitaoka M
Ther Apher Dial; 2008 Oct; 12 Suppl 1():S16-20. PubMed ID: 19032521
[TBL] [Abstract][Full Text] [Related]
9. [A case of secondary hyperparathyroidism with an ectopic intrathyroid gland successfully diagnosed and controlled by percutaneous ethanol injection therapy (PEIT)].
Tanaka M; Itoh K; Matsushita K; Ogawa A; Hirayama H; Tsunoda N; Yoshizumi K; Naruse M; Nonoguchi H; Tomita K
Nihon Jinzo Gakkai Shi; 2002 May; 44(4):409-13. PubMed ID: 12073627
[TBL] [Abstract][Full Text] [Related]
10. New clinical guidelines for selective direct injection therapy of the parathyroid glands in chronic dialysis patients.
Onoda N; Fukagawa M; Tominaga Y; Kitaoka M; Akizawa T; Koiwa F; Kakuta T; Kurokawa K;
NDT Plus; 2008 Aug; 1(Suppl 3):iii26-iii28. PubMed ID: 25983969
[TBL] [Abstract][Full Text] [Related]
11. Long-term prognosis of parathyroid function after successful percutaneous ethanol injection therapy (PEIT) guided by color Doppler flow mapping in chronic dialysis patients.
Kakuta T; Kunimatsu K; Tadaki F; Fujisaki T; Noguchi M; Abe Y; Sakai H; Kurokawa K; Saito A
Biomed Pharmacother; 2000 Jun; 54 Suppl 1():60s-65s. PubMed ID: 10914993
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):48-52. PubMed ID: 15828906
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases.
Bennedbaek FN; Karstrup S; Hegedüs L
Eur J Endocrinol; 1997 Mar; 136(3):240-50. PubMed ID: 9100545
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonographic diagnosis of parathyroid glands and percutaneous ethanol injection therapy.
Kitaoka M
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():ii27-30. PubMed ID: 12771295
[TBL] [Abstract][Full Text] [Related]
15. [Ultrasonography-guided therapeutic procedures in the neck region].
Brzac HT
Acta Med Croatica; 2009 Dec; 63 Suppl 3():21-7. PubMed ID: 20235370
[TBL] [Abstract][Full Text] [Related]
16. Medical management after parathyroid intervention.
Tanaka M; Fukagawa M
NDT Plus; 2008 Aug; 1(Suppl 3):iii18-iii20. PubMed ID: 25983966
[TBL] [Abstract][Full Text] [Related]
17. Medical and surgical aspects of parathyroidectomy.
Fukagawa M; Tominaga Y; Kitaoka M; Kakuta T; Kurokawa K
Kidney Int Suppl; 1999 Dec; 73():S65-9. PubMed ID: 10633467
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism.
Koiwa F; Kakuta T; Tanaka R; Yumita S
Nephrol Dial Transplant; 2007 Feb; 22(2):522-8. PubMed ID: 17127701
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous ethanol (PEIT) and calcitrol (PCIT) injection therapy are ineffective in treating severe secondary hyperparathyroidism.
de Barros Gueiros JE; Chammas MC; Gerhard R; da Silva Dias Boilesen CF; de Oliveira IR; Moysés RM; Jorgetti V
Nephrol Dial Transplant; 2004 Mar; 19(3):657-63. PubMed ID: 14767023
[TBL] [Abstract][Full Text] [Related]
20. Complications of ultrasound guided percutaneous ethanol injection therapy of the thyroid and parathyroid glands.
Mauz PS; Stiegler M; Holderried M; Brosch S
Ultraschall Med; 2005 Apr; 26(2):142-5. PubMed ID: 15852178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
